| Year |
Citation |
Score |
| 2022 |
Kim M, Hui KM, Shi M, Reau N, Aloman C. Differential expression of hepatic cancer stemness and hypoxia markers in residual cancer after locoregional therapies for hepatocellular carcinoma. Hepatology Communications. PMID 36097402 DOI: 10.1002/hep4.2079 |
0.316 |
|
| 2019 |
Tomimaru Y, Aihara A, Wands JR, Aloman C, Kim M. A Novel Drug, CC-122, Inhibits Tumor Growth in Hepatocellular Carcinoma through Downregulation of an Oncogenic TCF-4 Isoform. Translational Oncology. 12: 1345-1356. PMID 31352197 DOI: 10.1016/J.Tranon.2019.07.002 |
0.384 |
|
| 2017 |
Iwagami Y, Casulli S, Nagaoka K, Kim M, Carlson RI, Ogawa K, Lebowitz MS, Fuller S, Biswas B, Stewart S, Dong X, Ghanbari H, Wands JR. Lambda phage-based vaccine induces antitumor immunity in hepatocellular carcinoma. Heliyon. 3: e00407. PMID 28971150 DOI: 10.1016/J.Heliyon.2017.E00407 |
0.442 |
|
| 2015 |
Iwagami Y, Huang CK, Olsen MJ, Thomas JM, Jang G, Kim M, Lin Q, Carlson RI, Wagner CE, Dong X, Wands JR. Aspartate β-hydroxylase modulates cellular senescence via glycogen synthase kinase 3β in hepatocellular carcinoma. Hepatology (Baltimore, Md.). PMID 26683595 DOI: 10.1002/Hep.28411 |
0.449 |
|
| 2015 |
Chung W, Kim M, de la Monte S, Longato L, Carlson R, Slagle BL, Dong X, Wands JR. Activation of signal transduction pathways during hepatic oncogenesis. Cancer Letters. PMID 26433160 DOI: 10.1016/J.Canlet.2015.09.016 |
0.403 |
|
| 2015 |
Xu CQ, de la Monte SM, Tong M, Huang CK, Kim M. Chronic Ethanol-Induced Impairment of Wnt/β-Catenin Signaling is Attenuated by PPAR-δ Agonist. Alcoholism, Clinical and Experimental Research. 39: 969-979. PMID 25903395 DOI: 10.1111/Acer.12727 |
0.354 |
|
| 2015 |
Huang CK, Yu T, de la Monte SM, Wands JR, Derdak Z, Kim M. Restoration of Wnt/β-catenin signaling attenuates alcoholic liver disease progression in a rat model. Journal of Hepatology. 63: 191-8. PMID 25724365 DOI: 10.1016/J.Jhep.2015.02.030 |
0.323 |
|
| 2014 |
Wands JR, Kim M. WNT/β-catenin signaling and hepatocellular carcinoma. Hepatology (Baltimore, Md.). 60: 452-4. PMID 24644061 DOI: 10.1002/Hep.27081 |
0.411 |
|
| 2014 |
Koga H, Kim M, Nakamura A, Yano H, Abe M, Ikezono Y, Nakamura T, Torimura T, Wands JR, Sata M. Abstract 330: The Wnt signal transcription factor TCF-4 directly regulates Bcl-xL expression in human hepatocellular carcinoma cells Cancer Research. 74: 330-330. DOI: 10.1158/1538-7445.Am2014-330 |
0.409 |
|
| 2013 |
Pez F, Lopez A, Kim M, Wands JR, Caron de Fromentel C, Merle P. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs. Journal of Hepatology. 59: 1107-17. PMID 23835194 DOI: 10.1016/J.Jhep.2013.07.001 |
0.443 |
|
| 2013 |
Tomimaru Y, Koga H, Yano H, de la Monte S, Wands JR, Kim M. Upregulation of T-cell factor-4 isoform-responsive target genes in hepatocellular carcinoma. Liver International : Official Journal of the International Association For the Study of the Liver. 33: 1100-12. PMID 23651211 DOI: 10.1111/Liv.12188 |
0.459 |
|
| 2013 |
Tomimaru Y, Xu CQ, Nambotin SB, Yan T, Wands JR, Kim M. Loss of exon 4 in a human T-cell factor-4 isoform promotes hepatic tumourigenicity. Liver International : Official Journal of the International Association For the Study of the Liver. 33: 1536-48. PMID 23648141 DOI: 10.1111/Liv.12189 |
0.429 |
|
| 2013 |
Tomimaru Y, Koga H, Shin TH, Xu CQ, Wands JR, Kim M. The SxxSS motif of T-cell factor-4 isoforms modulates Wnt/β-catenin signal activation in hepatocellular carcinoma cells. Cancer Letters. 336: 359-69. PMID 23562475 DOI: 10.1016/J.Canlet.2013.03.031 |
0.403 |
|
| 2013 |
Koga H, Kim M, Tomimaru Y, Nakamura T, Abe M, Hashimoto O, Ikezono Y, Masuda H, Yano H, Ueno T, Torimura T, Wands JR, Sata M. Abstract 890: Human TCF-4 isoforms regulate apoptosis through upregulating Bcl-xL expression in a SxxSS motif-dependent manner. Cancer Research. 73: 890-890. DOI: 10.1158/1538-7445.Am2013-890 |
0.401 |
|
| 2012 |
Koga H, Tsedensodnom O, Tomimaru Y, Walker EJ, Lee HC, Kim KM, Yano H, Wands JR, Kim M. Loss of the SxxSS motif in a human T-cell factor-4 isoform confers hypoxia resistance to liver cancer: an oncogenic switch in Wnt signaling. Plos One. 7: e39981. PMID 22768190 DOI: 10.1371/Journal.Pone.0039981 |
0.459 |
|
| 2011 |
Walker EJ, Rosenberg SA, Wands JR, Kim M. Role of Raf Kinase Inhibitor Protein in Hepatocellular Carcinoma. Forum On Immunopathological Diseases and Therapeutics. 2: 195-204. PMID 21984963 DOI: 10.1615/Forumimmundisther.V2.I2.110 |
0.463 |
|
| 2011 |
Nambotin SB, Wands JR, Kim M. Points of therapeutic intervention along the Wnt signaling pathway in hepatocellular carcinoma. Anti-Cancer Agents in Medicinal Chemistry. 11: 549-59. PMID 21554202 DOI: 10.2174/187152011796011019 |
0.46 |
|
| 2011 |
Tsedensodnom O, Koga H, Rosenberg SA, Nambotin SB, Carroll JJ, Wands JR, Kim M. Identification of T-cell factor-4 isoforms that contribute to the malignant phenotype of hepatocellular carcinoma cells. Experimental Cell Research. 317: 920-31. PMID 21256126 DOI: 10.1016/J.Yexcr.2011.01.015 |
0.5 |
|
| 2011 |
Nambotin SB, Lefrancois L, Sainsily X, Berthillon P, Kim M, Wands JR, Chevallier M, Jalinot P, Scoazec JY, Trepo C, Zoulim F, Merle P. Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma. Journal of Hepatology. 54: 288-99. PMID 21055837 DOI: 10.1016/J.Jhep.2010.06.033 |
0.425 |
|
| 2011 |
Koga H, Walker EJ, Tsedensodnom O, Wands JR, Kim M. Abstract 1933: Preferential ubiquitination of hypoxia-inducible factors depends on the SxxSS motif in human T-cell factor-4 isoforms derived from hepatocellular carcinoma Cancer Research. 71: 1933-1933. DOI: 10.1158/1538-7445.Am2011-1933 |
0.407 |
|
| 2010 |
Toyama T, Lee HC, Koga H, Wands JR, Kim M. Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migration. Molecular Cancer Research : McR. 8: 254-65. PMID 20103596 DOI: 10.1158/1541-7786.Mcr-09-0238 |
0.49 |
|
| 2010 |
Koga H, Walker EJ, Tsedensodnom O, Wands JR, Kim M. Abstract 4067: A T-cell factor-4 motif regulates the phenotype of hepatocellular carcinoma cells Cancer Research. 70: 4067-4067. DOI: 10.1158/1538-7445.Am10-4067 |
0.412 |
|
| 2010 |
Tsedensodnom O, Koga H, Wands JR, Kim M. Abstract 2959: Characterization and function of unique T-cell factor-4 splicing isoforms that exhibit tumor repressive phenotypes in hepatocellular carcinoma Cancer Research. 70: 2959-2959. DOI: 10.1158/1538-7445.Am10-2959 |
0.481 |
|
| 2008 |
Kim M, Lee HC, Tsedensodnom O, Hartley R, Lim YS, Yu E, Merle P, Wands JR. Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells. Journal of Hepatology. 48: 780-91. PMID 18313787 DOI: 10.1016/J.Jhep.2007.12.020 |
0.453 |
|
| 2006 |
Lee HC, Tian B, Sedivy JM, Wands JR, Kim M. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology. 131: 1208-17. PMID 17030190 DOI: 10.1053/J.Gastro.2006.07.012 |
0.421 |
|
| 2006 |
Lee HC, Kim M, Wands JR. Wnt/Frizzled signaling in hepatocellular carcinoma. Frontiers in Bioscience : a Journal and Virtual Library. 11: 1901-15. PMID 16368566 DOI: 10.2741/1933 |
0.334 |
|
| 2006 |
Bengochéa A, Souza MMD, Lefrançois L, Trépo C, Kim M, Wands JR, Hainaut P, Scoazec JY, Vitvitski L, Merle P. O.085 Overexpression of the Wnt/Frizzled signal's memebers: A strikingly common and early event in human hepatocellular carcinoma (HCC) Journal of Clinical Virology. 36. DOI: 10.1016/S1386-6532(06)80085-5 |
0.42 |
|
| 2006 |
Wands JR, Merle P, Monte Sdl, Kim M, Herrmann M, Tanaka S, Bussche AVD, Kew MC, Trépo C. O.084 Role of frizzled-7 receptor overexpression in HBV and HCV related human hepatocellular carcinoma Journal of Clinical Virology. 36. DOI: 10.1016/S1386-6532(06)80084-3 |
0.355 |
|
| 2006 |
Bengochea A, Souza MD, Lefrancois L, Trepo C, Kim M, Wands JR, Hainaut P, Scoazec JY, Vitvitski L, Merle P. 347 Overexpression of the Wnt/frizzled signal's members: A common and early event in human hepatocellular carcinoma (HCC) Journal of Hepatology. 44. DOI: 10.1016/S0168-8278(06)80347-8 |
0.433 |
|
| 2005 |
Merle P, Kim M, Herrmann M, Gupte A, Lefrançois L, Califano S, Tre´po C, Tanaka S, Vitvitski L, Monte Sdl, Wands JR. Oncogenic role of the frizzled-7/β-catenin pathway in hepatocellular carcinoma Journal of Hepatology. 43: 854-862. PMID 16098625 DOI: 10.1016/J.Jhep.2005.05.018 |
0.493 |
|
| 2004 |
Merle P, Monte Sdl, Kim M, Herrmann M, Tanaka S, Bussche AVD, Kew MC, Trepo C, Wands JR. Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma. Gastroenterology. 127: 1110-1122. PMID 15480989 DOI: 10.1053/J.Gastro.2004.07.009 |
0.477 |
|
| 2003 |
Adinolfi E, Kim M, Young MT, Di Virgilio F, Surprenant A. Tyrosine phosphorylation of HSP90 within the P2X7 receptor complex negatively regulates P2X7 receptors. The Journal of Biological Chemistry. 278: 37344-51. PMID 12869560 DOI: 10.1074/Jbc.M301508200 |
0.316 |
|
| 2003 |
Merle P, Delamonte S, Herrmann M, Tanaka S, Kim M, Trepo C, Wands J. 834 Functional consequences of frizzled-7 receptor over-expression in human hepatocellular carcinoma Hepatology. 38: 564-564. DOI: 10.1016/S0270-9139(03)80876-5 |
0.412 |
|
| 2001 |
Kim M, Jiang LH, Wilson HL, North RA, Surprenant A. Proteomic and functional evidence for a P2X7 receptor signalling complex. The Embo Journal. 20: 6347-58. PMID 11707406 DOI: 10.1093/Emboj/20.22.6347 |
0.323 |
|
| 2001 |
Kim M, Spelta V, Sim J, North RA, Surprenant A. Differential assembly of rat purinergic P2X7 receptor in immune cells of the brain and periphery. The Journal of Biological Chemistry. 276: 23262-7. PMID 11313357 DOI: 10.1074/Jbc.M102253200 |
0.305 |
|
| Show low-probability matches. |